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Background: While the evidence-base concerning the economic impact of cancer for patients and their families/
carers has grown in recent years, there is little known about how emotional responses to cancer influence this
economic impact. We investigated the economic costs of cancer in the context of patients’ emotions and how
these both shaped the patient and family burden.
Methods: Health professionals from six hospitals invited patients diagnosed with colorectal cancer (ICD10 C18-C20)
within the previous year to take part in the study. Semi-structured face-to-face interviews were conducted with
patients and, where available, a family member. Interviews covered medical and non-medical costs incurred as a
result of cancer and the impact of these on the lives of the patient and their family. Interviews were audio-
recorded. Recordings were transcribed verbatim and these data were analysed qualitatively using thematic content
analysis.
Results: Twenty-two patients with colorectal cancer (17 colon and 5 rectal; 14 women and 8 men) were
interviewed; 6 were accompanied by a family member. Important cancer-related financial outlays included: travel
and parking associated with hospital appointments; costs of procedures; increased household bills; and new
clothing. Cancer impacted on employed individuals’ ability to work and depressed their income. The opportunity
cost of informal care for carers/family members, especially immediately post-diagnosis, was a strong theme. All
patients spoke of the emotional burden of colorectal cancer and described how this burden could lead to further
costs for themselves and their families by limiting work and hindering their ability to efficiently manage their
expenses. Some patients also spoke of how economic and emotional burdens could interact with each other.
Support from employers, family/carers and the state/health services and patients’ own attitudes influenced this
inter-relationship.
Conclusions: The economic impact of colorectal cancer on patients and their families is complex. This study
suggests that the economic costs and the emotional impact of cancer are often related and can exacerbate each
other, but that various factors can meditate this inter-relationship.
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More than one million people are diagnosed with colo-
rectal cancer (CRC) worldwide each year (Parkin, 2005).
The disease is responsible for more than half a million
deaths annually, mostly in developed countries [1,2].
Due to population ageing in developed countries, num-
bers of CRC cases are rising and are expected to con-
tinue rising in the coming years [2,3]. Survival too has
been increasing [4]. As a result of these trends more
people are living for longer with the disease.
This increase in new cases and survivors has implica-
tions for health services, patients and their families, and
society as a whole. The National Cancer Institute esti-
mated that the direct medical, indirect morbidity and in-
direct mortality costs of cancer in the United States in
2010 totalled over $260 billion [5]. CRC is thought to
constitute more than 10% of this burden in the USA [6].
Emerging evidence from other settings also suggests the
health services cost associated with CRC are significant
[7-11]. As more people require treatment and treat-
ments become more expensive, these costs are likely to
increase. Evidence too has emerged, though in lesser
quantities, on patient costs. One study estimated that
time costs relating to treatment alone over a CRC
patient's lifetime are in excess of $4,500 [12]. To date,
studies of patient-borne costs have considered time and
travel, out-of-pocket expenses (both medical and non-
medical) and employment issues [12-14], although, in
most instances, these have been assessed in isolation
from each other, despite the fact that patients may ex-
perience costs concurrently. Furthermore, much of the
previous research has been performed against the back-
drop of either predominantly publicly-funded [13,15-17]
or privately-funded healthcare systems [12,18].
Other costs of cancer for patients and their families in-
clude the emotional costs, which may be severe. Patients
and caregivers may experience fear, anxiety, depression
and anger [19-21]. While studies have examined the eco-
nomic and emotional consequences of CRC, to the best
of our knowledge there has been no investigation of the
inter-relationships between the two. Given the complex
nature of both of these burdens it is possible that there
are important dynamics at work which might not be eas-
ily detected using quantitative research methods.
Using a qualitative approach, we aimed to investigate
the broad spectrum of economic and emotional conse-
quences faced by CRC patients, the inter-relationships
between these and meditating factors. The setting was
Ireland, which is one of the few countries where a uni-
versal access health system coexists with private health
insurance (PHI) and where patients are free to move be-
tween the two. Moreover, the dispersed nature of the
population [22] in conjunction with the ongoing central-
isation of cancer services [23] could mean that patientissues, such as travel difficulties, emerge more strongly
here than in other settings.Methods
Setting
The public health system in Ireland is available to all but
most pay for GP appointments, prescription drugs and
make co-payments towards the cost of inpatient stays.
Possession of a medical card covers these costs and co-
payments. Medical cards are means-tested for people
under 70 and, for most of the study period, were univer-
sally available to those aged 70 and older. Cancer
patients without a medical card at the time of diagnosis
may apply for a card afterwards on hardship grounds.
The typical cost of a GP appointment is €50. The most
commonly-held private PHI plans cost in the region of
€1,000 per adult per annum and cover hospital in-pa-
tient stays, but not necessarily outpatient or primary
care visits. The maximum co-payment a patient without
either a medical card or PHI can make for an inpatient
stay is €75 per day, up to a maximum of €750 in any 12
consecutive months. Public and private hospitals are
often co-located and movement by patients between the
two is common. Approximately half of the population is
covered by PHI, 30% possess a medical card and 27%
have neither [24].Subjects
The study was part of a larger programme of work in-
vestigating the overall economic impact of colorectal
cancer. Subjects were recruited from six hospitals which
included large Centres of Excellence [23], specialist on-
cology units and hospices. Patients were eligible if they
had been diagnosed with a primary, invasive CRC (ICD
10: C18-C20) within the previous 12 months. Sampling
was purposive to ensure diversity of age, gender, disease
extent, treatment pathways, residence characteristics
(urban or rural) and employment situations.
There was no relationship between the investigators
and participants before the study began. Clinicians and
specialist nurses involved in the care of CRC patients
assisted with recruitment by making initial approaches
to potentially eligible individuals. They explained the
study and provided an information sheet which
described the study aims in general terms (i.e. to investi-
gate the economic impact of cancer on patients and
their families). Details of those who were potentially
interested in taking part were forwarded to the research
team, one of whom contacted them by post and/or
phone to confirm their willingness to be interviewed and
arrange an interview date and location. Where appropri-
ate, and with the agreement of the patient, the re-
searcher also invited a family member (generally a
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tient (a carer) to be interviewed.
Interviews
Interviews were conducted between August 2007 and
October 2009. They were face-to-face, took place in a lo-
cation of the participant’s choosing (usually the patient’s
home), and lasted 60–90 minutes. Where present, carers
were interviewed alongside the patient. Interviews were
conducted by two team members (AOC, CF) who were
already employed as researchers on the programme on
the overall economic impact of cancer. They had both
undergone training in qualitative methods and specific-
ally in conducting interviews with cancer patients (Clin-
ical Research Collaboration Cymru training programme).
Before the interview, participants were given another
chance to review the information sheet and ask any
questions they might have. They then provided signed
informed consent.
Interviews were semi-structured around a topic guide.
This guide was informed by literature review, discus-
sions with health professionals, a brainstorming session
with a national bowel cancer support group and semi-
structured interviews with hospital-based oncology so-
cial workers that were conducted for a parallel study in-
volving patients with other cancers [25]. The topic guide
covered: the socio-demographic characteristics of the pa-
tient and their family; the patients’ care pathway; the
economic consequences of cancer for patients and their
family/carers; and the emotional impact of cancer.
No repeat interviews were conducted. The inter-
viewers liaised at several points during the course of the
fieldwork to discuss data saturation. Recruitment ceased
once new themes/issues stopped emerging.
Analysis
With the participants’ consent, interviews were recorded
and transcribed verbatim. Written notes of participants
were also taken by the researchers during interviews. An
experienced qualitative researcher (LC) undertook the
analysis. This was a phenomenological study, in which
emphasis was placed on the subjective meaning for indi-
viduals surrounding their experience [26], with the aim
of exploring, in detail, how participants made sense of
their personal and social world [27]. A thematic content
analysis was conducted. All themes were derived from
the data and not determined in advance. Interviews were
coded and analysed manually, to facilitate an iterative
approach, keeping track of individual experience, and
how different factors and themes impact on this experi-
ence. Recordings and transcripts were listened to and
read repeatedly. Codes and themes were identified
through these repeat readings and review of the tran-
scripts. Converging and diverging representations ofeach theme were identified across transcripts. A cross-
comparative approach was taken, referring back and
forth between the raw data, the codes and the emerging
themes throughout the process of analysis, in order to
confirm and validate conclusions drawn. Information on
the impact of cancer on carers was provided by both the
carers themselves and also by the patient where the
carer was not present.
Transcripts were not returned to interviewees and
they were not invited to provide feedback on the study’s
findings, though they were offered a summary of the
study results.Ethical approval
Approval for the study was obtained from the research
ethics committees covering the six hospitals from which
subjects were recruited, namely: Our Lady’s Hospice
Harold’s Cross Research Ethics Committee; the Clinical
Research Ethics Committee of the Cork Teaching Hospi-
tals (for Cork University Hospital and Mercy University
Hospital); St Luke's Hospital Research Management
Committee; St Vincent’s Healthcare Group Ethics and
Medical Research Committee; and Galway Research Eth-
ics Committee (site specific approval for University Col-
lege Hospital Galway).Results
Characteristics of participants
In total, 22 patients and 6 carers (4 spouses and 2
daughters) were interviewed. Patients’ characteristics are
shown in Table 1. They ranged in age from 44 to 82; 17
had been diagnosed with colon cancer and 5 with rectal
cancer; 14 were women and 8 men; 13 lived in urban
areas while 9 were from more rural parts of the country.Themes
The major themes that emerged from the interviews
were: out-of-pocket costs (both medical and non-med-
ical), “making ends meet” (i.e. managing financially), the
role of family and friends, services and entitlements, and
emotional costs (Figure 1).Out-of-pocket costs
Most respondents had a medical card, PHI, or (in some
instances) both, and were largely satisfied with the cover
these provided. None of those with a medical card
reported any costs relating directly to their hospital care,
GP visits or prescription items. However, some patients
with PHI found themselves having to pay substantial
amounts for outpatient appointments and for proce-
dures/tests. In some cases the type and extent of these
costs was an unwelcome surprise.
Table 1 Participant characteristics
VARIABLE GROUPING N
Cancer site Colon: 17
Rectal: 5
Age less than 50 years: 2
50-59 years: 2
60-69 years: 12
70 and older: 6
Sex female: 14
male: 8
Area of residence urban1: 13
rural: 9
Medical card at time of interview yes: 16
no: 6
Private health insurance at diagnosis yes: 9
no: 132
Employment status at diagnosis retired: 13
working: 8
unemployed: 1
Received sick-pay from employer yes: 6
no: 2
not applicable: 14





1 ‘Urban’ includes those residing in cities; ‘rural’ includes all other patients
2 One participant had neither health insurance nor a medical card.
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altogether. Eight visits to consultants and that would
have come to a cost of €960 and the insurance paid
€640 of that (Pt019).
I had probably three or four ultrasounds and scans.
€200 a pop (Pt004).
Those without medical cards noted that regular post-
treatment GP visits constituted a substantial ongoing
cost. Some also paid the full contribution of €85 per
month to a publicly-subsidised prescription drug scheme
when purchasing supportive medications. Several items
had to be paid for in full by all respondents, most com-
monly over-the-counter painkillers and mouthwash for
chemotherapy-induced ulcers. These were not regarded
as significant expenses by patients.
Travel costs to and from the hospital for treatment
were important for all interviewees, especially so for
those who had chemotherapy and/or radiotherapy, be-
cause this required more hospital visits. Some spoke ofthe difficulties they experienced in using public trans-
port, especially because of journey length or treatment
side-effects.
[It took] at least an hour, yeah. . . . It [the bus] leaves
at ten to nine, oh more than an hour. It would be
nearly two. Around 11 [o’clock] you get there, with all
the stops and stuff (Pt020).
Interviewees appreciated the efforts of some hospitals
to provide free transport and/or parking. However the
limitations of such schemes (scarcity in the case of park-
ing and journey length in the case of free transport)
sometimes rendered them functionally useless because
patients were so frail.
They’d provide me with transport if I wanted. . . . You
could be two or three hours driving. And you wouldn’t
be able for that, you know? (Pt037).
Some respondents had increased utility bills following
diagnosis, particularly for the telephone and heating.
They noted that this was because they were at home
more and because (neo)adjuvant therapies could make
them more susceptible to feeling cold. For some, these
extra costs caused real hardship.
Our bills last year. . .were €370. He was so cold. . . .
[It’s] gas and we would have . . . lighting as well. . . .
And the heating on as well. . . .Oh God it [The cost]
was dreadful. Really dreadful (Spouse of PT007).
Other household expenses, such as home alterations
required because of limitations in mobility following
treatment (for example, one family had to build a down-
stairs extension as the patient could no longer manage
the stairs), could be very high, but were incurred by few
patients. Almost all patients described how treatment-
related changes in their bodies, such as weight loss, and/
or accommodating a stoma made it necessary for them
to buy new clothes. The associated costs ranged from in-
cidental to burdensome (when an entirely new wardrobe
was required).
Making ends meets
Eight interviewees were working at diagnosis. Six of
these interviewees received some sick pay from their
employers and all were very appreciative of employer
understanding, both in terms of time off and sick pay
provision. Despite this support, all employed participants,
including those who received sick pay, noted a drop in
income post-diagnosis; in some cases the drop was sub-
stantial. This was particularly so in situations where an
individual had to retire early or work fewer hours.
Figure 1 Themes arising from interviews with patients and carers.
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reckon I lost €4,000. You know eight months at about
€500 (Pt015).
Two respondents who were working at diagnosis
retired immediately. Both were unhappy with having to
leave work but felt compelled to do so.
I worked in childcare. I was in the running of a pre-
school. . . . I had to give it up. I didn’t have to but I
felt, I was advised there was a risk of infection with
small children. . . . And then – it’s a very physical job.
They all need lifting (Pt025).
Some carers also took time off work following the
diagnosis. For some, this leave was unpaid or had to be
taken as part of holiday entitlements. In one instance,
where the patient was receiving palliative care, his
daughter left her job to become his full-time carer.
A few interviewees were self-employed and a cancer
diagnosis could be especially challenging for them. Gen-
erally, these individuals felt pressure to continue working
regardless of their health, even though it might be diffi-
cult to cope. One entrepreneur described how his diag-
nosis nearly caused his business to fold.
But . . .I had got behind. . .obviously sending out
accounts. . ..I was only half functioning and it took a
while and that’s where I got in trouble you know
(Pt004).
Those in other areas of self-employment such as farm-
ing were able to draw on the support of family andfriends in keeping their business going. One described
how his son took annual leave to help on the farm fol-
lowing the initial diagnosis while ongoing support was
provided by his wife and a neighbour.
Those who took time off work were anxious to return
as soon as possible. Being on a reduced income was
keenly felt. One interviewee sought to bring forward his
surgery so that he could get back to work sooner.
I said [to the consultant] ‘I’m not worried about the
cancer . . . however, I do have a financial concern.’
Because he was saying ‘If I can’t get you an early
December [surgery date] . . . we’ll leave it until January
or maybe February.’ So more months waiting, more
months on half pay. So he said ‘I’ll definitely get you in
regardless, by early December’ (Pt012).
For those not working at diagnosis, the financial and
economic impact of cancer was even more pronounced;
these individuals generally had smaller pre-diagnosis
incomes and cancer-related costs could have a severe
impact, reducing their means considerably. One patient
described how the high cost of hospital parking meant
that she could not afford a cup of tea in the canteen.
Another noted:
And then we’d have to be getting coffees and that up
there [the hospital] sometimes and a sandwich, you
know . . . So it cost a pretty packet (PT034).
Some described having to cut back on spending to
make ends meet. Some used their savings, and found
that savings accumulated over years could be exhausted
very quickly.
Well I just had a bit of money put by. It wasn’t
much. . . Take €50 from it. . . . Take [another] €50 and
it would be gone then before you knew where you were
(Pt007).
Savings could also function as a buffer allowing fam-
ilies to maintain their standard of living in the face of
increased expenditure and/or reduced income.
I would've been in a bad way, I’d say, if I hadn’t have
had them savings behind. We can live the lifestyle
we’re used to because of those savings. . . . I mean
they’re dwindling now but, thank God I had them
(Pt034).
The role of family and friends
All patients received some practical support from fam-
ilies and/or friends. This took many forms including
help at home or with travel; support in the form of
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cing; or financial assistance. Some patients came to rely
on this support, especially with respect to travelling to
and from hospital. Emotional support was also provided.
Patients noted that a carer could sometime have a great
impact on their wellbeing through the security provided
by knowing that they (the carer) were there if needed.
Patients were very appreciative of the practical and emo-
tional support they received.
They [ my sons and daughters] organised a kind of a
roster. . . . So that there would be somebody in hand.
As it happened when I got out after the blockage
problem, my wife took sick herself. She got a blessed
virus which really debilitated her and again the family
had to organise and cook lunch or dinner for us, you
know. (PT026).
my daughter is in Y. And she works up here in X. And
she loops around to make sure [I’m ok]. . .if one of
them isn’t checking on me the other one is. I am well
minded (PT009).
I’d be lost without [my daughter]. (PT034).
The role of family and friends in providing support
was most pronounced for older respondents, especially
where infirmity meant the patient’s spouse was unable to
provide help. In contrast, there was also a strong sense
among older patients that they needed to preserve their
independence.
I’d say “I’m fine” and then my neighbour next door, she
would insist on driving me in [to the hospital]. It was
driving me mad because I only had to go to the end of
the hill to get the bus.... But I was fine and it’s nice to
have a bit of independence. (Pt009).
Patients were mindful that the support they received
often protected them from a whole range of expenses
that they would otherwise have had to bear. In some
instances, they described how the support meant they
could preserve their savings. All agreed that without this
support their situation would have been much more
challenging.
Services & entitlements
In the main, patients were knowledgeable about the vari-
ous potential supports that might be available to them
within the health and social welfare system, such as the
drug payment scheme or medical cards. This awareness
came from a number of sources including health care
providers and prior knowledge. Patients who were taking
advantage of these services were quite happy with the
cover provided. However, a number of difficulties were
described. Some patients found the process of applyingfor a medical card unduly arduous and embarrassing.
Such feelings were shared by those who had been suc-
cessful in their application and those who had not.
It [the medical card] was a bit hard to get. . . . Very,
very hard. . . . They [the community welfare officers
who adjudicate on applications] really humiliate you.
It’s horrible (spouse of Pt007).
Some poor experiences resulted from conflicting or
confusing information about entitlements.
I have a friend working in the Health Board ..... I
remember at the time she had said to me that I should
be entitled to a temporary medical card. . . . . When I
went about it, I got a very negative kind of reaction.
And I was told “no” (Pt016).
Patients’ attitudes affected the way in which they
engaged with services. One participant had, based on
personal experiences, a negative opinion regarding bene-
fits of any kind and did not seek support even where he
knew it was available.
You’ve only gurriers and gougers living around here.
They’re drunk seven days a week and work is a dirty
word. And yet I don’t know how I missed out on it [A
perceived easy life on benefits]. St. Vincent de Paul is
sending them to Wales for the summer. Not for two
weeks, three weeks and where does PT007 go? (PT007).
Others viewed benefits as entitlements following a life-
time of social insurance contributions and were comfort-
able accessing services or applying for benefits. One
patient spoke of an active process of informing herself.
I’m very good about whatever is there .......all the
services are there and you would be a fool if you didn’t
[take them up] (PT009).
The emotional impact of colorectal cancer
All patients spoke about the emotional cost of CRC
for them and their families. Even where economic issues
were not a cause of worry in and of themselves, the
emotional consequences took their toll.
Financially, I had a good packet in the job, you know,
so I’m not destitute by any stretch of the imagination.
But I mean in terms of emotional stress and strains,
stuff like that, this illness has cost us (PT034).
Accessing health and social services could also
cause emotional strain, because of unhelpful or in-
sensitive staff, or due to the specific circumstances or
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edly, required to pay for scans before the results would
be released. She described feeling threatened by this.
Some patients described how a lack of public know-
ledge or understanding of CRC could lead to social em-
barrassment. One patient described taking the bus home
after chemotherapy:
And I asked the bus driver would he close the door.
Oh God. He turned around to the rest of the bus [and
said] ‘This lady wants to close the door and we’re all
dying with the heat, she says she’s cold.’ . . . Oh God.
And I just wanted to explain ‘I’m not just cold, I’m
sick.’ (PT025).
For families too, the emotional impact of cancer could
be significant. Often family members or carers had other
stressors in their lives (such as pregnancy and moving
house) and the cancer diagnosis represented an added
emotional burden.
It’s putting more pressure on them[family members or
carers] and they are worried about you and everything
else (Pt009).
Interviewees described how the economic and emo-
tional impacts of cancer were inter-related, both posi-
tively and negatively. One patient felt compelled to retire
early from employment and was left with a deep sense
of injustice about this. Another, who was successful in
applying for a medical card, described the difference this
made to her emotional wellbeing.
I got ill just after I retired. . . . It wasn’t fair. Because
all I done all my life was work, from the time I was
eleven years old. In those days you didn’t pay tax or
PRSI (Pt007).
That was such a blessing to get that medical card
because it took [away] an awful lot of pressure and
worry. (Pt025).
In addition, the emotional strain could cause new eco-
nomic concerns, on top of those resulting directly from the
cancer diagnosis. In one instance a spouse who had already
taken annual leave to be with her husband around the time
of his diagnosis and treatment was forced to take more
leave as a result of the emotional strain she had endured.
She was quite upset. So she took that day completely
off work. And there was scattered days she took off, you
know (Pt012).
For others, the stress that cancer caused meant they
were less able to keep track of day-to-day spending.It could have been more [money spent] . . . See, I never
kept notes. . . . See, I usually keep notes but I was so ill
for him, that my mind. . . [was not as focused]
(PT007).
Discussion
Our patients covered a range of ages, disease stages, care
journeys, personal circumstances and socio-economic
backgrounds. Colorectal cancer affects men and women
in approximately equal measure; therefore we were able
to ensure that gender perspectives on cancer and its eco-
nomic and emotional impacts were considered. Our sam-
ple included several people whose cancer was no longer
curable (, though none was at the very end of life). The
issues faced by these patients were not fundamentally dif-
ferent to those of other patients who were cancer-free.
The inclusion of carers and family members in our study
added their perspective to that of patients and provided
more insight into the experiences of patients themselves.
Usually, carers’ perspectives are investigated separately
from that of patients [12,15,16,18,19,28,29]. Markman et
al (2010) [30] did explore cancer-related out-of-pocket
costs from the perspective of the family as a whole but
this study did not consider the multi-dimensional na-
ture of the economic impact of the disease. The qualita-
tive nature of our study allowed us to extend the
existing body of evidence on “costs” of cancer (in its
widest sense) and explore both economic and emotional
costs, how these interact, and how patient and family
experiences, attitudes, and external supports influence
them. These issues would be unlikely to emerge from a
quantitative study.
In recent years, a consensus has begun to emerge
regarding the core components of the economic burden
of cancer for patients and their families [13,30,31]. Can-
cer-related expenses may include treatment costs (par-
ticularly in private healthcare systems), treatment-related
travel and parking costs, household costs, and personal
care costs (such as clothing). However, much of the pre-
vious literature pertains to breast and prostate cancer;
CRC has been relatively under investigated. The age and
socio-economic distribution of CRC differs from breast
and prostate cancer and treatment patterns differ [32],
making it possible that the nature of costs and their im-
pact on patients will differ. In fact, our findings were
largely consistent with the literature, suggesting that, at
least in part, the mere fact of having a cancer is what
impacts on patients economically, irrespective of the
type of cancer. Furthermore, it is worth noting that pri-
vate health insurance did not provide any protection
from non-medical costs; all patients we interviewed bore
such costs.
Although economic costs are important in and of
themselves, the interplay between these costs and the
Figure 2 Conceptual model of interrelationship between economic and emotional consequences and mediating factors.
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of equal importance. It is clear from this study and
others that cancer causes emotional strain for patients
and their families [31,33]. Moreover, some have shown
that financial distress in cancer patients can also cause
emotional difficulties [34,35]. Our study suggests that
this is a two-way relationship (see Figure 2). Not only
can economic strain cause emotional distress, the emo-
tional toll of colorectal cancer has the potential to influ-
ence the economic situation of the patient and caregiver
beyond the effect of the diagnosis itself. This gives rise
to a situation where a family could face a direct eco-
nomic loss from cancer that was exacerbated by further
economic losses relating to their emotional state follow-
ing diagnosis. This in turn could cause yet more emo-
tional problems. This negative feedback between
economic and emotional consequences of cancer has the
potential to make difficult situations even worse.
Our findings further suggest that the factors that
can exacerbate, alleviate, moderate or prevent this
negative feedback loop are multi-faceted. The patient’s
employment circumstances and income are of majorimportance. Our results would suggest that patients
experience these issues not just in directly monetary
terms but in relation to how they impact on their own
lives and those of their families.
Sick pay has previously been shown to be an import-
ant determinant of work resumption post-cancer in Ire-
land [36]. This study reveals that it is an important
mediator of the economic-emotional impact of the dis-
ease. With adequate sick pay, the loss of income was
greatly reduced and this in turn meant that patients wor-
ried less about their financial situation; hence financial
stress was not added to the stress due to the cancer
diagnosis and could not exacerbate any existing eco-
nomic issues for the patient. On the other hand, in some
instances, the consequences of being absent from work
with inadequate sick pay were such that they influenced
treatment decisions. This finding is consistent with the
existing literature [37,38].
The availability of familial support can also impact on
the emotional-economic strain for patients [39]. Using
qualitative methods, Bradley et al [31] examined the role
of family and friends in providing economic support, but
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on patient wellbeing. In our study, patients frequently
spoke at great length about the things that family and
friends had done to improve their lives, or to show that
they cared, or to help out financially. This meant that,
through the attention of family/friends, patients often
avoided a great degree of economic outlay and emo-
tional strain. The importance of support provided by
family in this study is consistent with findings of another
Irish study of breast, prostate and lung cancer patients
[25] and may reflect strong family cohesion in Ireland
[40] compared to other countries in northern Europe.
Further research would be valuable in clarifying whether
the role of family support is as strong in other settings.
Patients themselves could influence the cycle of eco-
nomic and emotional strain by engaging with available
health and social welfare services. A small number of
patients had received conflicting or wrong information
on their entitlement to supports, especially medical
cards. This often led to confusion and embarrassment
for patients when they were informed that their applica-
tion for support had failed. Evidence from the UK sug-
gests that benefits available to cancer patients often go
unclaimed [34], meaning that patients and their families
are assuming unnecessary burdens. This observation, to-
gether with our findings, suggests that more and better
communication with cancer patients regarding their
entitlements is needed. There is also a need to provide
this information in a way that avoids triggering issues
around benefits that can prevent people from claiming
these even when entitled (such as stigma) [41].
Conclusions
Our study shows that the economic impact of colorectal
cancer for patients and their families is complex and
suggest that there is a strong inter-relationship between
the economic and emotional impact of the disease. Sup-
port from the family, workplace and state/health ser-
vices, and patients’ own attitudes can interrupt this
negative cycle, allowing patients and families to cope
better with what is already an incredibly challenging
time in their lives. Further studies are needed to confirm
these findings in other health and social welfare settings.
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